Advertisement
Screener

Five Prime Therapeutics, Inc. Operating Expenses

Five Prime Therapeutics, Inc. Operating Expenses

Five Prime Therapeutics, Inc. reported Operating Expenses of $106.05 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2021-03-22

  • Five Prime Therapeutics, Inc. operating expenses for the quarter ending 2020-12-31 was $21.27M, a 39.75% decline year-over-year.
  • Five Prime Therapeutics, Inc. operating expenses for the quarter ending 2020-09-30 was $35.16M, a 12.44% decline year-over-year.
  • Five Prime Therapeutics, Inc. operating expenses for the quarter ending 2020-06-30 was $20.57M, a 47.38% decline year-over-year.
  • Five Prime Therapeutics, Inc. operating expenses for the quarter ending 2020-03-31 was $29.05M, a 31.27% decline year-over-year.
  • Five Prime Therapeutics, Inc. operating expenses for fiscal 2020 was $106.05M, a 32.37% decline from fiscal 2019.
  • Five Prime Therapeutics, Inc. operating expenses for fiscal 2019 was $156.81M, a 20.00% decline from fiscal 2018.
  • Five Prime Therapeutics, Inc. operating expenses for fiscal 2018 was $196.02M, a 2.68% increase from fiscal 2017.
  • Five Prime Therapeutics, Inc. operating expenses for fiscal 2017 was $190.91M, a 46.96% increase from fiscal 2016.
Period endOperating Expenses 3 monthOperating Expenses 6 monthOperating Expenses 9 monthOperating Expenses 12 month
2020-12-31$21.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22
$56.43M
derived: sum of 2 quarters · filed 2021-03-22
$77.00M
derived: sum of 3 quarters · filed 2021-03-22
$106.05M
10-K · filed 2021-03-22
2020-09-30$35.16M
10-Q · filed 2020-11-03
$55.73M
derived: sum of 2 quarters · filed 2020-11-03
$84.77M
10-Q · filed 2020-11-03
$120.08M
derived: sum of 4 quarters · filed 2021-03-22
2020-06-30$20.57M
10-Q · filed 2020-08-06
$49.62M
10-Q · filed 2020-08-06
$84.92M
derived: sum of 3 quarters · filed 2021-03-22
$125.08M
derived: sum of 4 quarters · filed 2021-03-22
2020-03-31$29.05M
10-Q · filed 2020-05-07
$64.36M
derived: sum of 2 quarters · filed 2021-03-22
$104.51M
derived: sum of 3 quarters · filed 2021-03-22
$143.60M
derived: sum of 4 quarters · filed 2021-03-22
2019-12-31$35.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22
$75.46M
derived: sum of 2 quarters · filed 2021-03-22
$114.55M
derived: sum of 3 quarters · filed 2021-03-22
$156.81M
10-K · filed 2021-03-22
2019-09-30$40.15M
10-Q · filed 2020-11-03
$79.24M
derived: sum of 2 quarters · filed 2020-11-03
$121.50M
10-Q · filed 2020-11-03
$165.81M
derived: sum of 4 quarters · filed 2021-03-22
2019-06-30$39.09M
10-Q · filed 2020-08-06
$81.35M
10-Q · filed 2020-08-06
$125.66M
derived: sum of 3 quarters · filed 2021-03-22
$180.18M
derived: sum of 4 quarters · filed 2021-03-22
2019-03-31$42.26M
10-Q · filed 2020-05-07
$86.58M
derived: sum of 2 quarters · filed 2021-03-22
$141.09M
derived: sum of 3 quarters · filed 2021-03-22
$184.26M
derived: sum of 4 quarters · filed 2021-03-22
2018-12-31$44.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22
$98.83M
derived: sum of 2 quarters · filed 2021-03-22
$141.99M
derived: sum of 3 quarters · filed 2021-03-22
$196.02M
10-K · filed 2021-03-22
2018-09-30$54.52M
10-Q · filed 2019-11-06
$97.68M
derived: sum of 2 quarters · filed 2019-11-06
$151.71M
10-Q · filed 2019-11-06
$194.86M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$43.16M
10-Q · filed 2019-08-08
$97.19M
10-Q · filed 2019-08-08
$140.34M
derived: sum of 3 quarters · filed 2020-02-27
$192.75M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$54.03M
10-Q · filed 2019-05-09
$97.18M
derived: sum of 2 quarters · filed 2020-02-27
$149.59M
derived: sum of 3 quarters · filed 2020-02-27
$200.69M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$43.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$95.56M
derived: sum of 2 quarters · filed 2020-02-27
$146.66M
derived: sum of 3 quarters · filed 2020-02-27
$190.91M
10-K · filed 2020-02-27
2017-09-30$52.41M
10-Q · filed 2018-11-06
$103.51M
derived: sum of 2 quarters · filed 2018-11-06
$147.76M
10-Q · filed 2018-11-06
$187.43M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$51.11M
10-Q · filed 2018-08-08
$95.35M
10-Q · filed 2018-08-08
$135.02M
derived: sum of 3 quarters · filed 2019-02-26
$168.06M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$44.25M
10-Q · filed 2018-05-08
$83.92M
derived: sum of 2 quarters · filed 2019-02-26
$116.95M
derived: sum of 3 quarters · filed 2019-02-26
$147.24M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$39.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$72.71M
derived: sum of 2 quarters · filed 2019-02-26
$102.99M
derived: sum of 3 quarters · filed 2019-02-26
$129.90M
10-K · filed 2019-02-26
2016-09-30$33.04M
10-Q · filed 2017-11-06
$63.32M
derived: sum of 2 quarters · filed 2017-11-06
$90.23M
10-Q · filed 2017-11-06
$119.79M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$30.28M
10-Q · filed 2017-08-08
$57.20M
10-Q · filed 2017-08-08
$86.75M
derived: sum of 3 quarters · filed 2018-02-27
$116.69M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$26.91M
10-Q · filed 2017-05-05
$56.47M
derived: sum of 2 quarters · filed 2018-02-27
$86.40M
derived: sum of 3 quarters · filed 2018-02-27
$104.31M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$29.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$59.49M
derived: sum of 2 quarters · filed 2018-02-27
$77.40M
derived: sum of 3 quarters · filed 2018-02-27
$92.83M
10-K · filed 2018-02-27
2015-09-30$29.93M
10-Q · filed 2016-11-04
$47.84M
derived: sum of 2 quarters · filed 2016-11-04
$63.27M
10-Q · filed 2016-11-04
$79.81M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30$17.91M
10-Q · filed 2016-08-05
$33.34M
10-Q · filed 2016-08-05
$49.88M
derived: sum of 3 quarters · filed 2017-02-24
$63.04M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31$15.43M
10-Q · filed 2016-05-06
$31.97M
derived: sum of 2 quarters · filed 2017-02-24
$45.13M
derived: sum of 3 quarters · filed 2017-02-24
$60.03M
derived: sum of 4 quarters · filed 2017-02-24
2014-12-31$16.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$29.70M
derived: sum of 2 quarters · filed 2017-02-24
$44.60M
derived: sum of 3 quarters · filed 2017-02-24
$56.80M
10-K · filed 2017-02-24
2014-09-30$13.16M
10-Q · filed 2015-11-05
$28.06M
derived: sum of 2 quarters · filed 2015-11-05
$40.27M
10-Q · filed 2015-11-05
$51.38M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30$14.90M
10-Q · filed 2015-08-07
$27.10M
10-Q · filed 2015-08-07
$38.22M
derived: sum of 3 quarters · filed 2016-03-11
$49.02M
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31$12.21M
10-Q · filed 2015-05-14
$23.32M
derived: sum of 2 quarters · filed 2016-03-11
$34.13M
derived: sum of 3 quarters · filed 2016-03-11
$45.10M
derived: sum of 4 quarters · filed 2016-03-11
2013-12-31$11.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
$21.92M
derived: sum of 2 quarters · filed 2016-03-11
$32.89M
derived: sum of 3 quarters · filed 2016-03-11
$43.21M
10-K · filed 2016-03-11
2013-09-30$10.80M
10-Q · filed 2014-11-12
$21.77M
derived: sum of 2 quarters · filed 2014-11-12
$32.09M
10-Q · filed 2014-11-12
$41.88M
derived: sum of 4 quarters · filed 2015-03-18
2013-06-30$10.97M
10-Q · filed 2014-08-07
$21.29M
10-Q · filed 2014-08-07
$31.08M
derived: sum of 3 quarters · filed 2015-03-18
$39.85M
derived: sum of 4 quarters · filed 2015-03-18
2013-03-31$10.32M
10-Q · filed 2014-05-12
$20.11M
derived: sum of 2 quarters · filed 2015-03-18
$28.88M
derived: sum of 3 quarters · filed 2015-03-18
2012-12-31$9.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18
$18.56M
derived: sum of 2 quarters · filed 2015-03-18
$37.79M
10-K · filed 2015-03-18
2012-09-30$8.77M
10-Q · filed 2013-11-13
$28.00M
10-Q · filed 2013-11-13
2011-12-31$45.26M
10-K · filed 2014-03-26